Tradestie Institutional Equity Comparison Engine

EQ vs MRK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MRK Overall Edge

MRK Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Merck & Co., Inc. (MRK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while EQ counters with relative strength in Valuation. Fundamentally, EQ trades at 1.5x Forward P/E with 0.0% operating margin (-52.3% YoY revenue) versus MRK at 14.8x Forward P/E and 35.2% operating margin (+4.7% YoY). In options structure, EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against MRK sits in CONSOLIDATION (28th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
EQ 1.5x vs MRK 14.8x Fwd P/E
Growth & Margin Winner MRK
Op Margin 0.0% vs 35.2% ยท YoY -52.3% vs +4.7%
Momentum & Technical Winner MRK
1Y +12.0% vs +37.7% ยท 52W Pos 11% vs 63%
Options & Structure Winner MRK
UNCLASSIFIED (100th %ile IV) vs CONSOLIDATION (28th %ile IV)
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
1M Return -21.13%
1Y Return +12.0%
Forward P/E 1.5x
Unified AI Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0
MRK NYSE
Merck & Co., Inc.
Pharmaceutical Preparations
$132.81
-3.61% 1D
Market Cap $339.7B
1M Return -11.39%
1Y Return +37.73%
Forward P/E 14.8x
Unified AI Score
50.8 / 100 HOLD
Tech 23.0 Fund 47.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EQ +12.0% MRK +37.73% Spread: +25.73 pp (MRK Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EQ Revenue MRK Revenue EQ Op. Margin MRK Op. Margin Margin Edge
FY2018 N/A $42.3B N/A 14.7% MRK
FY2019 N/A $39.1B N/A 25.2% MRK
FY2020 N/A $41.5B N/A 17.0% MRK
FY2021 N/A $48.7B N/A 26.8% MRK
FY2022 $20M $59.3B -393.9% 24.5% MRK
FY2023 $40M $60.1B -40.2% 0.6% MRK
FY2024 $40M $64.2B -20.1% 26.7% MRK
FY2025 N/A $65.0B N/A 28.1% MRK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EQ (2) vs MRK (8)
Institutional Metric EQ MRK Criterion Row Winner
Market Capitalization Scale $90.6M $339.7B Larger Scale MRK
Trailing P/E Ratio Valuation 1.5x 139.2x Lower Multiple EQ
Forward P/E Ratio Valuation 1.5x 14.8x Lower Multiple EQ
Revenue Growth (YoY) Growth -52.3% +4.7% Higher Growth MRK
Operating Margin (TTM) Profitability 0.0% 35.2% Higher Margin MRK
Net Profit Margin Profitability 0.0% 3.6% Higher Margin MRK
Return on Equity (ROE) Capital Efficiency -59.0% 5.1% Higher ROE MRK
52-Week Range Position Momentum 11% ($1โ€“$4) 63% ($92โ€“$157) Stronger Trend MRK
Beta / 30D Volatility Risk Regime 1.53ฮฒ ยท 93% Vol 0.27ฮฒ ยท 34% Vol Lower Realized Risk MRK
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 50.8 / 100 (HOLD) Higher Composite MRK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EQ vs MRK Buy Guide
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MRK CONSOLIDATION
61d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 28th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MRK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EQ nor MRK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.